Literature DB >> 27094714

Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes.

Wardit Tigchelaar1, Anne Margreet de Jong1, Vincent W Bloks2, Wiek H van Gilst1, Rudolf A de Boer1, Herman H W Silljé3.   

Abstract

Cardiac hypertrophy is associated with growth and functional changes of cardiomyocytes, including mitochondrial alterations, but the latter are still poorly understood. Here we investigated mitochondrial function and dynamic localization in neonatal rat ventricular cardiomyocytes (NRVCs) stimulated with insulin like growth factor 1 (IGF1) or phenylephrine (PE), mimicking physiological and pathological hypertrophic responses, respectively. A decreased activity of the mitochondrial electron transport chain (ETC) (state 3) was observed in permeabilized NRVCs stimulated with PE, whereas this was improved in IGF1 stimulated NRVCs. In contrast, in intact NRVCs, mitochondrial oxygen consumption rate (OCR) was increased in PE stimulated NRVCs, but remained constant in IGF1 stimulated NRVCs. After stimulation with PE, mitochondria were localized to the periphery of the cell. To study the differences in more detail, we performed gene array studies. IGF1 and PE stimulated NRVCs did not reveal major differences in gene expression of mitochondrial encoding proteins, but we identified a gene encoding a motor protein implicated in mitochondrial localization, kinesin family member 5b (Kif5b), which was clearly elevated in PE stimulated NRVCs but not in IGF1 stimulated NRVCs. We confirmed that Kif5b gene and protein expression were elevated in animal models with pathological cardiac hypertrophy. Silencing of Kif5b reverted the peripheral mitochondrial localization in PE stimulated NRVCs and diminished PE induced increases in mitochondrial OCR, indicating that KIF5B dependent localization affects cellular responses to PE stimulated NRVCs. These results indicate that KIF5B contributes to mitochondrial localization and function in cardiomyocytes and may play a role in pathological hypertrophic responses in vivo.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte; Heart; Hypertrophy; Kif5b; Mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27094714     DOI: 10.1016/j.yjmcc.2016.04.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Dynamic culture yields engineered myocardium with near-adult functional output.

Authors:  Christopher P Jackman; Aaron L Carlson; Nenad Bursac
Journal:  Biomaterials       Date:  2016-09-30       Impact factor: 12.479

Review 2.  Cardiomyocyte Microtubules: Control of Mechanics, Transport, and Remodeling.

Authors:  Keita Uchida; Emily A Scarborough; Benjamin L Prosser
Journal:  Annu Rev Physiol       Date:  2021-10-06       Impact factor: 22.163

Review 3.  Motor proteins at the mitochondria-cytoskeleton interface.

Authors:  Antonina J Kruppa; Folma Buss
Journal:  J Cell Sci       Date:  2021-04-13       Impact factor: 5.285

4.  Transcriptional, Post-Transcriptional, and Post-Translational Mechanisms Rewrite the Tubulin Code During Cardiac Hypertrophy and Failure.

Authors:  Sai Aung Phyo; Keita Uchida; Christina Yingxian Chen; Matthew A Caporizzo; Kenneth Bedi; Joanna Griffin; Kenneth Margulies; Benjamin L Prosser
Journal:  Front Cell Dev Biol       Date:  2022-04-01

5.  Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder.

Authors:  Chenxu Ge; Linfeng Hu; Deshuai Lou; Qiang Li; Jing Feng; Yekuan Wu; Jun Tan; Minxuan Xu
Journal:  Aging (Albany NY)       Date:  2020-03-17       Impact factor: 5.682

Review 6.  Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy.

Authors:  Dan Yang; Han-Qing Liu; Fang-Yuan Liu; Zhen Guo; Peng An; Ming-Yu Wang; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.